{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:52:04Z","timestamp":1793944324908,"version":"4.8.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009431","name":"Humanitas University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009431","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.euo.2025.10.012","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T16:02:39Z","timestamp":1763568159000},"page":"459-471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognostic Role of Different T1 Substaging Systems on Recurrence and Progression in Non\u2013muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-6601-1244","authenticated-orcid":false,"given":"Andrea","family":"Piccolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Moretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6155-5964","authenticated-orcid":false,"given":"Vittorio","family":"Fasulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Uleri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Finocchiaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Dagnino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Paolo","family":"Avolio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Saita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Lazzeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Casale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Lughezzani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2 Maria","family":"Buffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piergiuseppe","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Paciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2025.10.012_b0005","article-title":"EAU guidelines on non-muscle-invasive bladder cancer (TaT1 and CIS)","author":"Gontero","year":"2024","journal-title":"EAU"},{"key":"10.1016\/j.euo.2025.10.012_b0010","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.euo.2024.09.006","article-title":"Risk of progression in patients with primary T1 high grade non-muscle invasive bladder cancer \u2013 a contemporary cohort","volume":"8","author":"Pijpers","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0015","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.euo.2023.07.012","article-title":"Oncological outcomes for patients with European Association of Urology very high-risk non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin or early radical cystectomy","volume":"6","author":"Contieri","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0020","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.eururo.2016.02.028","article-title":"The 2016 WHO classification of tumours of the urinary system and male genital organs\u2014part B: prostate and bladder tumours","volume":"70","author":"Humphrey","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0025","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.euf.2016.06.004","article-title":"Feasibility and clinical roles of different substaging systems at first and second transurethral resection in patients with T1 high-grade bladder cancer","volume":"4","author":"Colombo","year":"2018","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.10.012_b0030","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.eururo.2011.10.026","article-title":"A new and highly prognostic system to discern T1 bladder cancer substage","volume":"61","author":"Van Rhijn","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0035","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13000-016-0466-6","article-title":"Usefulness of pT1 substaging in papillary urothelial bladder carcinoma","volume":"11","author":"Patriarca","year":"2016","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","article-title":"Risk stratification tools and prognostic models in non\u2013muscle-invasive bladder cancer: a critical assessment from the European Association of Urology Non-muscle-invasive Bladder Cancer Guidelines Panel","volume":"6","author":"Soukup","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.euo.2025.10.012_b0045","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/his.14764","article-title":"What\u2019s new in WHO fifth edition\u2009\u2013\u2009urinary tract","volume":"81","author":"Comp\u00e9rat","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.euo.2025.10.012_b0050","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.10.012_b0055","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.10.012_b0060","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.euo.2025.10.012_b0065","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta\u2010analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/j.euo.2025.10.012_b0070","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.eururo.2018.12.014","article-title":"Guidelines for reporting of statistics for clinical research in urology","volume":"75","author":"Assel","year":"2019","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0075","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000132700","article-title":"Does the expression of fascin-1 and tumor subclassification help to assess the risk of recurrence and progression in T1 urothelial urinary bladder carcinoma?","volume":"80","author":"Soukup","year":"2008","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.10.012_b0080","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/j.1365-2559.2011.03989.x","article-title":"Substaging by estimating the size of invasive tumour can improve risk stratification in pT1 urothelial bladder cancer-evaluation of a large hospital-based single-centre series","volume":"59","author":"Bertz","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.euo.2025.10.012_b0085","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.humpath.2012.04.020","article-title":"Prognostic factors in T1 bladder urothelial carcinoma: the value of recording millimetric depth of invasion, diameter of invasive carcinoma, and muscularis mucosa invasion","volume":"44","author":"Brimo","year":"2013","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0090","doi-asserted-by":"crossref","first-page":"317","DOI":"10.4111\/kju.2012.53.5.317","article-title":"Prognostic significance of substaging according to the depth of lamina propria invasion in primary T1 transitional cell carcinoma of the bladder","volume":"53","author":"Lee","year":"2012","journal-title":"Korean J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0095","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.juro.2012.11.120","article-title":"Prognostic interest in discriminating muscularis mucosa invasion (T1a vs T1b) in nonmuscle invasive bladder carcinoma: French national multicenter study with central pathology review","volume":"189","author":"Roupr\u00eat","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0100","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s12253-019-00767-1","article-title":"Comparative application of different substaging techniques for non-muscle invasive urothelial carcinoma","volume":"26","author":"Eldin","year":"2020","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.euo.2025.10.012_b0105","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1159\/000515650","article-title":"Substaging of pT1 urothelial bladder carcinoma predicts tumor progression and overall survival","volume":"106","author":"Grobet-Jeandin","year":"2022","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.10.012_b0110","doi-asserted-by":"crossref","first-page":"573","DOI":"10.5858\/arpa.2023-0044-OA","article-title":"pT1 subclassification predicts progression-free survival in en bloc resection of bladder tumor specimens","volume":"148","author":"Sato","year":"2024","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.euo.2025.10.012_b0115","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00345-024-05410-6","article-title":"Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-grade non-muscle invasive bladder cancer: results from a large single centre series","volume":"43","author":"Finati","year":"2024","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0120","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.eururo.2005.04.013","article-title":"Initial high-grade T1 urothelial cell carcinoma: Feasibility and prognostic significance of lamina propria invasion microstaging (T1a\/b\/c) in BCG-treated and BCG-non-treated patients","volume":"48","author":"Orsola","year":"2005","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0125","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1159\/000355358","article-title":"The prognostic value of T1 bladder cancer substaging: a single institution retrospective study","volume":"92","author":"Soukup","year":"2014","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.10.012_b0130","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1097\/JU.0000000000001630","article-title":"Vertical lamina propria invasion diagnosed by en bloc transurethral resection is a significant predictor of progression for pT1 bladder cancer","volume":"205","author":"Yanagisawa","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0135","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.5858\/arpa.2021-0175-OA","article-title":"Subcategorization of T1 bladder cancer on biopsy and transurethral resection specimens for predicting progression","volume":"146","author":"Budina","year":"2022","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.euo.2025.10.012_b0140","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s00428-024-03907-4","article-title":"A single-center retrospective comparison of pT1 substaging methods in bladder cancer","volume":"486","author":"Kl\u00e4ger","year":"2025","journal-title":"Virchows Arch"},{"key":"10.1016\/j.euo.2025.10.012_b0145","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/his.15177","article-title":"Prognostic value of micrometric substaging in pT1 bladder cancer patients treated with en-bloc transurethral resection","volume":"85","author":"Yanagisawa","year":"2024","journal-title":"Histopathology"},{"key":"10.1016\/j.euo.2025.10.012_b0150","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1093\/jjco\/hyt120","article-title":"Clinicopathological analysis of patients with non-muscle-invasive bladder cancer: prognostic value and clinical reliability of the 2004 WHO classification system","volume":"43","author":"Nishiyama","year":"2013","journal-title":"Jpn J Clin Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fsurg.2021.704902","article-title":"T1 bladder cancer: comparison of the prognostic impact of two substaging systems on disease recurrence and progression and suggestion of a novel nomogram","volume":"8","author":"Asimakopoulos","year":"2021","journal-title":"Front Surg"},{"key":"10.1016\/j.euo.2025.10.012_b0160","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1097\/JU.0000000000001422","article-title":"T1 substaging of nonmuscle invasive bladder cancer is associated with bacillus Calmette-Gu\u00e9rin failure and improves patient stratification at diagnosis","volume":"205","author":"De Jong","year":"2021","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.humpath.2005.06.017","article-title":"A new system for substaging pT1 papillary bladder cancer: a prognostic evaluation","volume":"36","author":"Van Der Aa","year":"2005","journal-title":"Hum Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0170","doi-asserted-by":"crossref","first-page":"361.e7","DOI":"10.1016\/j.urolonc.2018.05.007","article-title":"Metric substage according to micro and extensive lamina propria invasion improves prognostics in T1 bladder cancer","volume":"36","author":"Fransen van de Putte","year":"2018","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0175","doi-asserted-by":"crossref","first-page":"934","DOI":"10.3390\/cancers15030934","article-title":"Prospective validation of the ROL system in substaging pT1 high-grade urothelial carcinoma: results from a mono-institutional confirmatory analysis in BCG treated patients","volume":"15","author":"Valeri","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.euo.2025.10.012_b0180","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1007\/s00345-019-02936-y","article-title":"Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis","volume":"38","author":"Kardoust Parizi","year":"2020","journal-title":"World J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0185","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.urology.2024.10.013","article-title":"A systematic review on the current landscape of T1 bladder cancer substaging","volume":"194","author":"P\u00e9rez-Aizpurua","year":"2024","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.10.012_b0190","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1097\/PAS.0b013e3180588283","article-title":"Further characterization of the muscle layers and lamina propria of the urinary bladder by systematic histologic mapping","volume":"31","author":"Paner","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0195","doi-asserted-by":"crossref","unstructured":"Cheng L, Neumann RM, Weaver AL, Spotts BE, Bostwick DG. Predicting cancer progression in patients with stage T1 bladder carcinoma. Vol 17.; 1999.","DOI":"10.1200\/JCO.1999.17.10.3182"},{"key":"10.1016\/j.euo.2025.10.012_b0200","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1097\/PAS.0b013e31823dafd3","article-title":"Prognostic significance in substaging of T1 urinary bladder urothelial carcinoma on transurethral resection","volume":"36","author":"Chang","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0205","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1097\/PAS.0000000000000964","article-title":"Analysis of T1 bladder cancer on biopsy and transurethral resection specimens comparison and ranking of T1 quantification approaches to predict progression to muscularis propria invasion","volume":"42","author":"Leivo","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0210","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/his.13247","article-title":"Stalk versus base invasion in pT1 papillary cancers of the bladder: improved substaging system predicting the risk of progression","volume":"71","author":"Lawless","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.euo.2025.10.012_b0215","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.eururo.2020.12.033","article-title":"European Association of Urology (EAU) prognostic factor risk groups for non\u2013muscle-invasive bladder cancer (NMIBC) incorporating the WHO 2004\/2016 and WHO 1973 classification systems for grade: an update from the EAU NMIBC Guidelines Panel","volume":"79","author":"Sylvester","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0220","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/bju.16293","article-title":"Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy","volume":"133","author":"Contieri","year":"2024","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.10.012_b0225","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/his.14307","article-title":"Feasibility and accuracy of pathological diagnosis in en-bloc transurethral resection specimens versus conventional transurethral resection specimens of bladder tumour: evaluation with pT1 substaging by 10 pathologists","volume":"78","author":"Yanagisawa","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.euo.2025.10.012_b0230","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.euo.2023.07.010","article-title":"En Bloc Versus Conventional Resection of Primary Bladder Tumor (eBLOC): a prospective, multicenter, open-label, phase 3 randomized controlled trial","volume":"6","author":"D\u2019Andrea","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0235","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/1097-0142(19900801)66:3<543::AID-CNCR2820660323>3.0.CO;2-R","article-title":"The usefulness of the level of the muscularis mucosae in the staging of invasive transitional cell carcinoma of the urinary bladder","volume":"66","author":"Younes","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.10.012_b0240","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/0090-4295(94)90134-1","article-title":"Significance of invasion to the muscularis mucosae on the progression of superficial bladder cancer","volume":"43","author":"Hasui","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.10.012_b0245","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S0022-5347(01)65044-4","article-title":"The importance of the depth of invasion in stage T1 bladder carcinoma: a prospective cohort study","volume":"157","author":"Holmang","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0250","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/S0090-4295(98)00374-4","article-title":"Microstaging of PT1 transitional cell carcinoma of the bladder: identification of subgroups with distinct risks of progression","volume":"52","author":"Smits","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.10.012_b0255","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1002\/(SICI)1097-0142(19990915)86:6<1035::AID-CNCR20>3.0.CO;2-D","article-title":"Substaging of T1 bladder carcinoma based on the depth of invasion as measured by micrometer: a new proposal","volume":"86","author":"Cheng","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.euo.2025.10.012_b0260","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1016\/S0022-5347(05)67706-3","article-title":"Outcomes after intravesical bacillus Calmette-Guerin are not affected by substaging of high grade T1 transitional cell carcinoma","volume":"163","author":"Kondylis","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0265","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0090-4295(00)00756-1","article-title":"Prognostic value of P53 nuclear accumulation and histopathologic features in T1 transitional cell carcinoma of the urinary bladder","volume":"56","author":"Shariat","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.10.012_b0270","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1097\/00005392-200101000-00011","article-title":"The predictive value of muscularis mucosae invasion and P53 over expression on progression of stage T1 bladder carcinoma","volume":"165","author":"Bernardini","year":"2001","journal-title":"J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0275","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1159\/000063941","article-title":"Microstaging of PT1 transitional cell carcinoma of the bladder does it really differentiate two populations with different prognoses? (PT1 subcategory)","volume":"69","author":"S\u00f6zen","year":"2002","journal-title":"Urol Int"},{"key":"10.1016\/j.euo.2025.10.012_b0280","first-page":"1447","article-title":"Significance of muscularis mucosae in metastasis involvement of urinary bladder transitional cell carcinoma","volume":"89","author":"Chaimuangraj","year":"2006","journal-title":"J Med Assoc Thai"},{"key":"10.1016\/j.euo.2025.10.012_b0285","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/00365590601183055","article-title":"Prognostic value of p53, Ki-67, microstaging and microvessel density in pT1G3 bladder tumors: creation of risk groups for progression","volume":"41","author":"Queipo-Zaragoza","year":"2007","journal-title":"Scand J Urol Nephrol"},{"key":"10.1016\/j.euo.2025.10.012_b0290","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.urology.2007.06.638","article-title":"Prognostic factors in stage T1 bladder cancer: tumor pattern (solid or papillary) and vascular invasion more important than depth of invasion","volume":"70","author":"Andius","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.euo.2025.10.012_b0295","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1464-410X.2007.07090.x","article-title":"Predicting outcome in minimally invasive (T1a and T1b) urothelial bladder carcinoma using a panel of biomarkers: a high throughput tissue microarray analysis","volume":"100","author":"Mhawech-Fauceglia","year":"2007","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.10.012_b0300","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1464-410X.2009.08694.x","article-title":"Risk factors for positive findings in patients with high-grade T1 bladder cancer treated with transurethral resection of bladder tumour (TUR) and bacille Calmette-Gu\u00e9rin therapy and the decision for a repeat TUR","volume":"105","author":"Orsola","year":"2010","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.10.012_b0305","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2011.10.029","article-title":"Female gender and carcinoma in situ in the prostatic urethra are prognostic factors for recurrence, progression, and disease-specific mortality in T1G3 bladder cancer patients treated with bacillus Calmette-Gu\u00e9rin","volume":"62","author":"Palou","year":"2012","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0310","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/00365599.2012.719539","article-title":"Population-based study on prognostic factors for recurrence and progression in primary stage T1 bladder tumours","volume":"47","author":"Olsson","year":"2013","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0315","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/bju.12364","article-title":"Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages","volume":"113","author":"Descotes","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2025.10.012_b0320","doi-asserted-by":"crossref","first-page":"575","DOI":"10.3892\/mco.2014.290","article-title":"Prognostic role of substaging in T1G3 transitional cell carcinoma of the urinary bladder","volume":"2","author":"De Marco","year":"2014","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/j.euo.2025.10.012_b0325","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.anndiagpath.2013.11.002","article-title":"Measuring the dimension of invasive component in pT1 urothelial carcinoma in transurethral resection specimens can predict time to recurrence","volume":"18","author":"Hu","year":"2014","journal-title":"Ann Diagn Pathol"},{"key":"10.1016\/j.euo.2025.10.012_b0330","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.eururo.2015.02.021","article-title":"A molecular pathologic framework for risk stratification of stage T1 urothelial carcinoma","volume":"68","author":"Patschan","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0335","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1038\/bjc.2014.633","article-title":"Reexamining treatment of high-grade T1 bladder cancer according to depth of lamina propria invasion: a prospective trial of 200 patients","volume":"112","author":"Orsola","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.euo.2025.10.012_b0340","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3346\/jkms.2015.30.8.1068","article-title":"Clinical significance of substaging and her2 expression in papillary nonmuscle invasive urothelial cancers of the urinary bladder","volume":"30","author":"Lim","year":"2015","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.euo.2025.10.012_b0345","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/iju.13532","article-title":"Infiltrative lamina propria invasion pattern as an independent predictor for cancer-specific and overall survival of instillation treatment-na\u00efve stage T1 high-grade urothelial bladder cancer","volume":"25","author":"Otto","year":"2018","journal-title":"Int J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0350","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1590\/s1677-5538.ibju.2017.0424","article-title":"Comparative differences between T1a\/b and T1e\/m as substages in T1 urothelial carcinoma of the bladder","volume":"44","author":"Turan","year":"2018","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.euo.2025.10.012_b0355","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4081\/aiua.2020.3.239","article-title":"The impact of tumor invasion to muscularis mucosae-vascular plexus on patient outcome in pT1 bladder urothelial carcinoma","volume":"92","author":"Sahan","year":"2020","journal-title":"Arch Ital Urol Androl"},{"key":"10.1016\/j.euo.2025.10.012_b0360","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1007\/s11255-020-02772-9","article-title":"Prognosis of patients with T1 bladder cancer after en bloc transurethral resection of bladder tumor stratified by invasion to the level of the muscularis mucosa","volume":"53","author":"Yasui","year":"2021","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.euo.2025.10.012_b0365","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1038\/s41598-023-29352-y","article-title":"A nomogram for predicting postoperative urosepsis following retrograde intrarenal surgery in upper urinary calculi patients with negative preoperative urine culture","volume":"13","author":"Yang","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.euo.2025.10.012_b0370","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/bju.16298","article-title":"A novel grading approach predicts worse outcomes in stage pT1 non-muscle-invasive bladder cancer","volume":"134","author":"Haas","year":"2024","journal-title":"BJU Int"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500286X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258893112500286X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T02:35:46Z","timestamp":1777602946000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258893112500286X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":74,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S258893112500286X"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2025.10.012","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Role of Different T1 Substaging Systems on Recurrence and Progression in Non\u2013muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2025.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}